Dow Up 0.03% Nasdaq Up 0.36%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
40.33 Down 0.43(1.05%) 11:09AM EDT - Nasdaq Real Time Price
Prev Close:40.76
Open:41.18
Bid:40.24 x 100
Ask:40.29 x 100
1y Target Est:45.50
Beta:1.67
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:39.64 - 41.28
52wk Range:22.25 - 62.66
Volume:710,382
Avg Vol (3m):2,122,770
Market Cap:4.75B
P/E (ttm):N/A
EPS (ttm):-0.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISDown 1.05%4.75B
ENZ 0.00%260.76M
GILDUp 0.92%164.09B
SRPTDown 2.97%910.54M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.75
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-2.31

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback